BFA
PLXP

BlackRock Fund Advisors’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

BlackRock Fund Advisors’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$26K Buy
2,052
+85
+4% +$3.12K ﹤0.01% 3856
2016
Q3 		$228K Buy
1,967
+8
+0.4% +$780 ﹤0.01% 3408
2016
Q2 		$155K Buy
1,959
+321
+20% +$27.8K ﹤0.01% 3549
2016
Q1 		$125K Sell
1,638
-107
-6% -$6.8K ﹤0.01% 3601
2015
Q4 		$156K Buy
+1,745
New +$167K ﹤0.01% 3621

Other funds holding PLXP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return
MC
Middleton & Co Boston, Massachusetts $877M AUM 15.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

BlackRock Fund Advisors's PLXP Position: Q4 2016 in Review

BlackRock Fund Advisors increased its PLx Pharma Inc. Common Stock (PLXP) stake by 4.3% in Q4 2016, buying an estimated $3.12K and bringing the position to 2,052 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #3856.

BlackRock Fund Advisors first reported a position in PLXP in Q4 2015 and has held it in 5 quarters since. The position peaked at $228K in Q3 2016. 19 funds tracked by Wall St. Rank hold PLXP as of Q4 2016.

  • BlackRock Fund Advisors held 2,052 shares of PLx Pharma Inc. Common Stock worth $26K as of Q4 2016.
  • BlackRock Fund Advisors bought 85 PLx Pharma Inc. Common Stock shares in Q4 2016, an estimated $3.12K.
  • PLx Pharma Inc. Common Stock made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3856 holding.
  • BlackRock Fund Advisors first reported a position in PLx Pharma Inc. Common Stock in Q4 2015 and has held it in 5 quarters since.
  • BlackRock Fund Advisors's PLx Pharma Inc. Common Stock position peaked at $228K in Q3 2016.
  • 19 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.